Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Vieillot

P1.04-31 Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Cancer Research

English

MA08.09 Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer

Oncology in Clinical Practice

English

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Current Treatment Options in Oncology

English

Effect of Sex on the Efficacy of Patients Receiving Immune Checkpoint Inhibitors in Advanced Non‐small Cell Lung Cancer

Cancer Medicine

Cancer Research

Nuclear Medicine

English

Immune Checkpoint Modulation for Non-Small Cell Lung Cancer

Clinical Cancer Research

Cancer Research

English

P1.01-63 Correlation Between Immune-Related Adverse Events and Efficacy of Immune-Checkpoint Inhibitors in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English